Ausgabe 12/2017
Inhalt (26 Artikel)
Human cancer stem cells are a target for cancer prevention using (−)-epigallocatechin gallate
Hirota Fujiki, Eisaburo Sueoka, Anchalee Rawangkan, Masami Suganuma
Fibrinogen promotes malignant biological tumor behavior involving epithelial–mesenchymal transition via the p-AKT/p-mTOR pathway in esophageal squamous cell carcinoma
Fei Zhang, Yun Wang, Peng Sun, Zhi-qiang Wang, De-shen Wang, Dong-sheng Zhang, Feng-hua Wang, Jian-hua Fu, Rui-hua Xu, Yu-hong Li
Traditional Chinese medicine as adjunctive therapy improves the long-term survival of lung cancer patients
Yueh-Hsiang Liao, Chia-Ing Li, Cheng-Chieh Lin, Jaung-Geng Lin, Jen-Huai Chiang, Tsai-Chung Li
TLR9 gene polymorphism −1486T/C (rs187084) is associated with uterine cervical neoplasm in Mexican female population
Cecilia Martínez-Campos, Margarita Bahena-Román, Kirvis Torres-Poveda, Ana I. Burguete-García, Vicente Madrid-Marina
Targeted next-generation sequencing for analyzing the genetic alterations in atypical adenomatous hyperplasia and adenocarcinoma in situ
Xuan Xu, Na Li, Ruiying Zhao, Lei Zhu, Jinchen Shao, Jie Zhang
Systemic Inflammation Response Index (SIRI), cancer stem cells and survival of localised gastric adenocarcinoma after curative resection
Sen Li, Xiuwen Lan, Hongyu Gao, Zhiguo Li, Li Chen, Wenpeng Wang, Shubin Song, Yimin Wang, Chunfeng Li, Hongfeng Zhang, Yingwei Xue
Modifiable health-related factors (smoking, physical activity and body mass index) and health care use and costs among adult cancer survivors
Sapna Kaul, Jaqueline C. Avila, Daniel Jupiter, Ana M. Rodriguez, Anne C. Kirchhoff, Yong-Fang Kuo
The more from East-Asian, the better: risk prediction of colorectal cancer risk by GWAS-identified SNPs among Japanese
Makiko Abe, Hidemi Ito, Isao Oze, Masatoshi Nomura, Yoshihiro Ogawa, Keitaro Matsuo
Karyopherin α-2 is a reliable marker for identification of patients with high-risk stage II colorectal cancer
Dongjun Jeong, Hyeongjoo Kim, Seona Ban, Seunghyun Oh, Sanghee Ji, Doyeon Kim, Tae Sung Ahn, Han Jo Kim, Sang Byung Bae, Hyog Young Kwon, Jungkyun Im, Moon Soo Lee, Hyun Deuk Cho, Chang-Jin Kim, Moo-Jun Baek
Prognostic role of progesterone receptor expression in a population-based analysis
Adele Caldarella, Alessandro Barchielli
Only SETBP1 hotspot mutations are associated with refractory disease in myeloid malignancies
Nils Winkelmann, Vivien Schäfer, Jenny Rinke, Alexander Kaiser, Philipp Ernst, Sebastian Scholl, Andreas Hochhaus, Thomas Ernst
Meeting report of the 6th Heidelberg Myeloma Workshop: current status and developments in diagnosis and therapy of multiple myeloma
Maximilian Merz, Marc S. Raab, Hartmut Goldschmidt, Jens Hillengass
Tumor response assessment: comparison between unstructured free text reporting in routine clinical workflow and computer-aided evaluation based on RECIST 1.1 criteria
Juliane Goebel, Julia Hoischen, Carolin Gramsch, Haemi P. Schemuth, Andreas-Claudius Hoffmann, Lale Umutlu, Kai Nassenstein
Can complementary medicine increase adherence to chemotherapy dosing protocol? A controlled study in an integrative oncology setting
Ilanit Shalom-Sharabi, Ofer Lavie, Noah Samuels, Lital Keinan-Boker, Efraim Lev, Eran Ben-Arye
Lenalidomide in combination with bendamustine and prednisolone in relapsed/refractory multiple myeloma: results of a phase 2 clinical trial (OSHO-#077)
Juliane Beck, Andreas Schwarzer, Dietrich Gläser, Lars-Olof Mügge, Jens Uhlig, Simone Heyn, Brigitte Kragl, Martin Mohren, Franz Albert Hoffmann, Thoralf Lange, Thomas Schliwa, Thomas Zehrfeld, Cornelia Becker, Ute Kreibich, Cornelia Winkelmann, Thomas Edelmann, Marc Andrea, Marius Bill, Madlen Jentzsch, Sebastian Schwind, Dietger Niederwieser, Wolfram Pönisch
Survival benefit of pelvic and paraaortic lymphadenectomy in high-grade endometrial carcinoma: a retrospective population-based cohort analysis
Thomas Papathemelis, S. Scharl, K. Kronberger, M. Gerken, A. Scharl, A. Pauer, M. Klinkhammer-Schalke
Prognostic stratification of patients with metastatic nasopharyngeal carcinoma using a clinical and biochemical scoring system
Jeremy Chee, Kwok Seng Loh, Ivan Tham, Francis Ho, Lea Choung Wong, Chee Seng Tan, Boon Cher Goh, Chwee Ming Lim
Identification of prognostic markers of high grade prostate cancer through an integrated bioinformatics approach
Hai Huang, Qin Zhang, Chen Ye, Jian-Min Lv, Xi Liu, Lu Chen, Hao Wu, Lei Yin, Xin-Gang Cui, Dan-Feng Xu, Wen-Hui Liu
Safety of intraoperative chemotherapy with 5-FU for colorectal cancer patients receiving curative resection: a randomized, multicenter, prospective, phase III IOCCRC trial (IOCCRC)
Rong-xin Zhang, Jun-zhong Lin, Jian Lei, Gong Chen, Li-ren Li, Zhen-hai Lu, Pei-rong Ding, Jiong-qiang Huang, Ling-heng Kong, Fu-long Wang, Cong Li, Wu Jiang, Chuan-feng Ke, Wen-hao Zhou, Wen-hua Fan, Qing Liu, De-sen Wan, Xiao-jun Wu, Zhi-zhong Pan
Validity of eleven prognostic scores with respect to intra- and extrahepatic recurrence of hepatocellular carcinoma after liver transplantation
A. Bauschke, A. Altendorf-Hofmann, H. Kissler, A. Koch, C. Malessa, U. Settmacher
Percutaneous irreversible electroporation combined with allogeneic natural killer cell immunotherapy for patients with unresectable (stage III/IV) pancreatic cancer: a promising treatment
Mao Lin, Shuzhen Liang, Xiaohua Wang, Yinqing Liang, Mingjie Zhang, Jibing Chen, Lizhi Niu, Kecheng Xu
Higher out-of-pocket expenses for tyrosine kinase-inhibitor therapy is associated with worse health-related quality-of-life in persons with chronic myeloid leukemia
Qian Jiang, Haibo Wang, Lu Yu, Robert Peter Gale
Assessing risk factors of acute kidney injury after liver transplantation
Gui-Zhen Yang, Fu-Shan Xue, Hui-Xian Li
Image-guided ablations in patients with thyroid tumors
Valerio Ferrara, Ciriaco Buonomenna, Giovanni Mauri